Susceptibility-based imaging aids accurate distinction of pediatric-onset MS from myelin oligodendrocyte glycoprotein antibody-associated disease

BACKGROUND: Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) and pediatric-onset multiple sclerosis (POMS) share clinical and magnetic resonance imaging (MRI) features but differ in prognosis and management. Early POMS diagnosis is essential to avoid disability accumulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sacco, Simone, Virupakshaiah, Akash, Papinutto, Nico, Schoeps, Vinicius A, Akula, Amit, Zhao, Haojun, Arona, Jennifer, Stern, William A, Chong, Janet, Hart, Janace, Zamvil, Scott S, Sati, Pascal, Henry, Roland G, Waubant, Emmanuelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687802/
https://www.ncbi.nlm.nih.gov/pubmed/37897254
http://dx.doi.org/10.1177/13524585231204414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687802/
https://www.ncbi.nlm.nih.gov/pubmed/37897254
http://dx.doi.org/10.1177/13524585231204414

Ejemplares similares